SPONSORED
By Elric Langton | 28 March 2023
Mike and I have a financial interest in SkinBioTherapeutics.
SkinBioTherapeutics Plc (AIM: SBTX - 14.50p), a life sciences company focused on skin health from the inside and out, announces its unaudited half-year consolidated results for the six months to 31 December 2022, which is regarded as rear-view mirror basβ¦